| Literature DB >> 35447895 |
Anne Pajot1, Gia Hao Huynh1, Laurent Picot2, Luc Marchal3, Elodie Nicolau1.
Abstract
Fucoxanthin is a brown-colored pigment from algae, with great potential as a bioactive molecule due to its numerous properties. This review aims to present current knowledge on this high added-value pigment. An accurate analysis of the biological function of fucoxanthin explains its wide photon absorption capacities in golden-brown algae. The specific chemical structure of this pigment also leads to many functional activities in human health. They are outlined in this work and are supported by the latest studies in the literature. The scientific and industrial interest in fucoxanthin is correlated with great improvements in the development of algae cultures and downstream processes. The best fucoxanthin producing algae and their associated culture parameters are described. The light intensity is a major influencing factor, as it has to enable both a high biomass growth and a high fucoxanthin content. This review also insists on the most eco-friendly and innovative extraction methods and their perspective within the next years. The use of bio-based solvents, aqueous two-phase systems and the centrifugal partition chromatography are the most promising processes. The analysis of the global market and multiple applications of fucoxanthin revealed that Asian companies are major actors in the market with macroalgae. In addition, fucoxanthin from microalgae are currently produced in Israel and France, and are mostly authorized in the USA.Entities:
Keywords: Tisochrysis lutea; biosynthesis; centrifugal partition chromatography; downstream processes; extraction; fucoxanthin; global market; golden-brown algae
Mesh:
Substances:
Year: 2022 PMID: 35447895 PMCID: PMC9027613 DOI: 10.3390/md20040222
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Figure 1Chemical structure of the fucoxanthin molecule.
Figure 2Isomers of fucoxanthin, all-trans fucoxanthin, 9′-cis fucoxanthin, 13-cis fucoxanthin, 13′-cis fucoxanthin.
Biological activities of fucoxanthin—studies of 2020–2021. The notation “p“ means the fucoxanthin was purchased and not directly purified from algae within the study.
| Property | Source of Fucoxanthin | Target | Reference |
|---|---|---|---|
| Anti-cancer | p | Mice pancreatic cancer cells | [ |
| p | Hamster pancreatic cancer cells | [ | |
| p | Mice colorectal cancer cells | [ | |
| p | Human colon cancer cells | [ | |
| p | Oral squamous cancer cells (KB) | [ | |
| p | Human glioblastoma cells (U87MG) | [ | |
|
| Human lung cancer cells | [ | |
| p | Human lung and cervical cancer cells | [ | |
| p | Nasopharyngeal carcinoma cells | [ | |
| Anti-inflammatory | p | Inflammation of mice tracheal epithelial cells | [ |
| p | Inflammation in non-alcoholic fatty liver disease | [ | |
|
| Particulate matter-induced inflammation | [ | |
| Lipopolysaccharide (LPS)- | [ | ||
| p | Neuroinflammatory response in induced-Parkinson’s disease | [ | |
| p | Acute lung injury inflammation | [ | |
|
| Immunocytes, enterocytes, mesenchymal stem cells | [ | |
|
| Pro-inflammatory cytokines | [ | |
| p | PAMP lipopolysaccharide-induced uveitis inflammation | [ | |
| Anti-obesity | p | Insulin resistance of obese mice | [ |
|
| Diet-induced obesity in rats | [ | |
| p | Gut microbiota in high-fat diet-fed mice | [ | |
|
| High-fat diet-fed mice | [ | |
| Anti-diabetes |
| Streptozotocin-nicotinamide-induced type 2 diabetic mice | [ |
| Protective effects | p | dexamethasone-induced myotubes atrophy | [ |
| p | Neurodegenerative disorders | [ | |
| p | 6-OHDA-Induced Neurotoxicity | [ | |
|
| Methamphetamine-induced neurotoxicity | [ | |
| p | High glucose-induced oxidative stress | [ | |
| p | Irradiated mice | [ | |
| p | Calcification of heart valve interstitial cells | [ | |
| p | Macular degeneration and retinal pigment epithelial cell senescence | [ | |
| p | Atopic dermatitis symptoms | [ | |
| p | Fibroblasts cellular senescence | [ | |
| p | Ischemia-reperfusion injury in kidney | [ | |
| p | UV-B irradiation induced retinal Müller cells | [ | |
| Anti-oxidant | 20-year meta-analysis review | [ | |
| Anti-microbial | Pathogenic bacteria ( | [ | |
| p | 20 bacterial species ( | [ | |
| p | review | [ | |
| Anti-Alzheimer |
| A | [ |
| Anti-osteoclastogenesis | p | MAP kinase, Nrf2 signaling | [ |
| Anti-urolithiatic | p | Ethylene glycol-induced renal calculus in rats | [ |
| Anti-fibrogenic | p | Hepatic stellate cells | [ |
Figure 3Hypothetic pathway of the fucoxanthin final synthesis reactions. Orange: genes implied in biosynthesis.
Microalgae species producing fucoxanthin in dried and fresh sample condition—studies of 2020–2022. The notation “-“ means that the data was not available.
| Species | Fx Content | Fx Productivity (mg·L−1·Day−1) | Condition | Reference | |
|---|---|---|---|---|---|
|
| haptophyte | 16.05 | 13.75 | dried | [ |
|
| haptophyte | 6.66 | 1.82 | dried | [ |
|
| haptophyte | 10.01 | 9.81 | dried | [ |
|
| haptophyte | 13.09 | - | dried | [ |
|
| haptophyte | 16.30 | 2.77 | dried | [ |
|
| haptophyte | 17.80 | 1.14 | dried | [ |
|
| haptophyte | 79.40 | - | dried | [ |
|
| haptophyte | 5.40 | - | dried | [ |
|
| haptophyte | 20.86 | 4.88 | dried | [ |
|
| haptophyte | 22.6 | 3.06 | dried | [ |
|
| diatom | 13.30 | 1.41 | dried | [ |
|
| diatom | 7.00 | - | dried | [ |
|
| diatom | 13.00 | 8.22 | dried | [ |
|
| diatom | 16.30 | - | dried | [ |
|
| diatom | 17.55 | - | dried | [ |
|
| diatom | 16.13 | - | dried | [ |
|
| diatom | 21.90 | - | fresh | [ |
|
| diatom | 21.20 | - | dried | [ |
|
| diatom | 17.51 | - | dried | [ |
|
| diatom | 11.80 | - | dried | [ |
|
| diatom | 5.90 | - | dried | [ |
|
| diatom | 9.00 | 5.10 | dried | [ |
|
| diatom | 16.20 | 9.41 | dried | [ |
|
| diatom | 41.83 | - | dried | [ |
|
| diatom | 12.20 | - | dried | [ |
|
| diatom | 10.00 | - | fresh | [ |
|
| diatom | 7.60 | 1.2 | fresh | [ |
|
| diatom | 5.70 | 0.60 | fresh | [ |
|
| diatom | 15.4 | 3.82 | fresh | [ |
Figure 4Schematic illustration of a close tubular air-lift photobioreactor and main culture parameters.
Carotenoids extraction with ionic liquids.
| Salt | Carotenoids Extracted | Reference |
|---|---|---|
| DACARB (diallyammonium diallycarbamate) | Fucoxanthin | [ |
| BF4− (tetrafluoborate) | Astaxanthin | [ |
| MS− (methylsulfate) | Astaxanthin | [ |
| ethanol + 1-n-butyl-3-methylimidazolium + Br− | Astaxanthin | [ |
Figure 5Example of a centrifugal partition chromatography purification process for the pigment separation of an extract of T. lutea.
Figure 6Applications and current market of fucoxanthin in food, cosmetics and medicine.